A detailed history of West Family Investments, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, West Family Investments, Inc. holds 20,861 shares of NVO stock, worth $1.82 Million. This represents 0.86% of its overall portfolio holdings.

Number of Shares
20,861
Previous 20,260 2.97%
Holding current value
$1.82 Million
Previous $2.89 Million 14.11%
% of portfolio
0.86%
Previous 0.9%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$119.07 - $145.42 $71,561 - $87,397
601 Added 2.97%
20,861 $2.48 Million
Q2 2024

Aug 05, 2024

SELL
$122.71 - $146.91 $232,535 - $278,394
-1,895 Reduced 8.55%
20,260 $2.89 Million
Q1 2024

May 13, 2024

SELL
$102.11 - $135.92 $222,089 - $295,626
-2,175 Reduced 8.94%
22,155 $2.84 Million
Q4 2023

Feb 06, 2024

SELL
$87.78 - $105.45 $34,058 - $40,914
-388 Reduced 1.57%
24,330 $2.52 Million
Q3 2023

Nov 02, 2023

BUY
$90.94 - $199.54 $1.01 Million - $2.22 Million
11,104 Added 81.56%
24,718 $2.25 Million
Q2 2023

Aug 15, 2023

BUY
$155.98 - $172.65 $34,627 - $38,328
222 Added 1.66%
13,614 $2.2 Million
Q4 2022

Feb 08, 2023

SELL
$102.55 - $135.33 $58,043 - $76,596
-566 Reduced 4.06%
13,392 $1.81 Million
Q3 2022

Nov 04, 2022

SELL
$95.28 - $116.93 $3,239 - $3,975
-34 Reduced 0.24%
13,958 $1.39 Million
Q2 2022

Aug 12, 2022

SELL
$103.24 - $121.81 $166,422 - $196,357
-1,612 Reduced 10.33%
13,992 $1.56 Million
Q4 2021

Feb 07, 2022

SELL
$95.88 - $117.08 $160,790 - $196,343
-1,677 Reduced 9.7%
15,604 $1.75 Million
Q3 2021

Oct 25, 2021

BUY
$84.42 - $106.62 $65,678 - $82,950
778 Added 4.71%
17,281 $1.66 Million
Q2 2021

Aug 12, 2021

BUY
$67.66 - $84.76 $1.12 Million - $1.4 Million
16,503 New
16,503 $1.38 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track West Family Investments, Inc. Portfolio

Follow West Family Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West Family Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on West Family Investments, Inc. with notifications on news.